Los Angeles Capital Management LLC Purchases 503 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Los Angeles Capital Management LLC increased its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 2.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 24,042 shares of the company’s stock after purchasing an additional 503 shares during the period. Los Angeles Capital Management LLC owned approximately 0.06% of Phibro Animal Health worth $505,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in PAHC. Rhumbline Advisers boosted its position in shares of Phibro Animal Health by 0.6% during the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after buying an additional 484 shares during the period. BNP Paribas Financial Markets lifted its stake in shares of Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after acquiring an additional 729 shares during the last quarter. New York State Teachers Retirement System boosted its holdings in Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after acquiring an additional 775 shares during the period. SG Americas Securities LLC grew its position in Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock valued at $276,000 after acquiring an additional 906 shares during the last quarter. Finally, Principal Financial Group Inc. increased its stake in Phibro Animal Health by 2.8% in the fourth quarter. Principal Financial Group Inc. now owns 98,783 shares of the company’s stock worth $2,074,000 after purchasing an additional 2,696 shares during the period. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Stock Performance

Shares of Phibro Animal Health stock opened at $24.52 on Tuesday. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The stock’s fifty day moving average price is $22.30 and its 200-day moving average price is $22.39. The firm has a market cap of $993.13 million, a P/E ratio of 51.08, a P/E/G ratio of 0.45 and a beta of 0.52. Phibro Animal Health Co. has a 12 month low of $11.98 and a 12 month high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities research analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is 100.00%.

Analyst Upgrades and Downgrades

PAHC has been the subject of a number of recent analyst reports. Barclays boosted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Finally, Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.